Cancer Patients Europe (CPE) is pleased to invite researchers, clinicians, patient representatives, policymakers, regulatory bodies, and industry stakeholders, to participate in the VOICE PM Networking Event: Meaningful Patient Involvement in Translational Personalised Medicine Research, taking place on 24-25 June 2026 in Brussels, Belgium. Organised as part of the VOICE PM networking project within the framework of the European Partnership for Personalised Medicine (EP PerMed).
The event will provide a unique opportunity for participants from previously funded ERA PerMed and EP PerMed projects, as well as Horizon Europe projects, patient organisations, healthcare professionals, researchers, policymakers, regulatory bodies, HTA experts, and industry representatives to exchange experiences and discuss practical approaches to patient engagement. Through presentations, discussions, and networking activities, participants will explore successful examples of patient involvement, identify common challenges, and contribute to recommendations that can support more patient-centred research and innovation.
The event is structured over two days:
- Wednesday, 24 June 2026 from 14:00 to 18:00 – Rue de l’Industrie 24, 1040 Brussels
- Thursday, 25 June 2026 from 09:00 to 17:30 – Skyline, Rue de Trèves 74, 1040 Brussels.
The second day will be integrated into the Cancer Patients Europe Annual Meeting. More information about the CPE Annual Meeting can be found here.
We look forward to welcoming you to Brussels for two days of discussion, collaboration, and knowledge exchange dedicated to strengthening meaningful patient involvement in personalised medicine research.
This network and event is supported under the frame of the European Partnership for Personalised Medicine, EP PerMed, (GA N° 101137129).
The views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Partnership for Personalised Medicine (EP PerMed), national/regional funding organisations, the European Union or the European Commission. Neither of these parties can be held responsible for them.